Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
52061
-
52062
Vanadium(V<sup>IV</sup>)–Porphyrin-Based Metal–Organic Frameworks for Synergistic Bimetallic Activation of Inert C(sp<sup>3</sup>)–H Bonds
Published 2022“…Taking advantage of the high stability of Zr<sub>6</sub> clusters, the new Zr–MOF was recyclable six times without a conversion efficiency decrease. From this foundation, {Mn<sub>3</sub>(μ<sub>3</sub>-O)} cluster nodes with potential unsaturated coordinated sites were introduced into MOFs to replace Zr<sub>6</sub> clusters, realizing the pre-activation of substrates through the interaction between Mn nodes and substrates. …”
-
52063
Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation
Published 2016“…Treatment with dasatinib caused a decrease in src-phosphorylation and inhibition of downstream pathways, including AKT and ERK1/2 in all cell lines tested, but only the MCF7-TAMR showed a concomitant decrease in markers of cell cycle progression. …”
-
52064
VEGF and sFlt-1 mutants exhibit changes in stem cell marker gene expression by RT-qPCR.
Published 2016“…(B) Bmi1 expression decreased 0.42 fold (*p = 0.03) and Wdr43 expression decreased 0.60 fold (*p = 0.004) in sFlt-1 mutants compared to littermates. sFlt-1 mutants demonstrated a 2.47-fold increase in expression of EphB2 (*p = 0.02) and a 1.50-fold increase in Sox9 expression (*p = 0.004); N = 6 mice per group; Error bars = STDEV.…”
-
52065
-
52066
-
52067
-
52068
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
52069
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
52070
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
52071
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
52072
Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter
Published 2023“…A more potent SERT inhibitor <b>DH4</b> was discovered with a bioavailability of 83.28% in rats by replacing the nonbioavailable substructure of approved drug vilazodone. …”
-
52073
-
52074
-
52075
-
52076
-
52077
-
52078
-
52079
-
52080